Clinical Trial Update: Immunologic Effects of HCV Therapy With HARVONI in HCV Genotype 1 Chronically Mono-infected Active and Former IDUs [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating immunologic effects of HARVONI therapy in Hepatitis C genotype 1 patients, including active and former IDUs; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• HARVONI (Ledipasvir and Sofosbuvir)

Snippet

Sponsor: Rockefeller University | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED | Results posted: 2019-08-13